References
- Håkonsen, H., K. A. Sundell, J. Martinsson, and T. Hedenrud. 2016. “Consumer Preferences for Over-the-Counter Drug Retailers in the Reregulated Swedish Pharmacy Market.” Health Policy 120 (3): 327–333. doi:10.1016/j.healthpol.2016.01.016.
- Keeler, T. E., T.-W. Hu, A. Keith, R. Manning, M. D. Marciniak, M. Ong, and H.-Y. Sung. 2002. “The Benefits of Switching Smoking Cessation Drugs to Over-the-Counter Status.” Health Economics 11 (5): 389–402. doi:10.1002/(ISSN)1099-1050.
- Ryan, M., and B. Yule. 1990. “Switching Drugs from Prescription-Only to Over-The-Counter Availability: Economic Benefits in the United Kingdom.” Health Policy 16 (3): 233–239. doi:10.1016/0168-8510(90)90424-C.
- Temin, P. 1992. “Realized Benefits from Switching Drugs.” Journal of Law & Economics 35 (2): 351–369. doi:10.1086/467258.